Cargando…
High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients
BACKGROUND: The Wnt inhibitor Dickkopf-1 (DKK-1) has been linked to the progression of malignant bone disease by impairing osteoblast activity. In addition, there is increasing data to suggest direct tumor promoting effects of DKK-1. The prognostic role of DKK-1 expression in prostate cancer remains...
Autores principales: | Rachner, Tilman D, Thiele, Stefanie, Göbel, Andy, Browne, Andrew, Fuessel, Susanne, Erdmann, Kati, Wirth, Manfred P, Fröhner, Michael, Todenhöfer, Tilman, Muders, Michael H, Kieslinger, Matthias, Rauner, Martina, Hofbauer, Lorenz C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167148/ https://www.ncbi.nlm.nih.gov/pubmed/25182503 http://dx.doi.org/10.1186/1471-2407-14-649 |
Ejemplares similares
-
Dickkopf-1 is regulated by the mevalonate pathway in breast cancer
por: Rachner, Tilman D, et al.
Publicado: (2014) -
Role of WNT5A receptors FZD5 and RYK in prostate cancer cells
por: Thiele, Stefanie, et al.
Publicado: (2018) -
p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells
por: Browne, A J, et al.
Publicado: (2016) -
Targeting syndecan-1 in breast cancer inhibits osteoclast functions through up-regulation of osteoprotegerin
por: Benad-Mehner, Peggy, et al.
Publicado: (2013) -
Dickkopf1 fuels inflammatory cytokine responses
por: Jaschke, Nikolai P., et al.
Publicado: (2022)